Picard Medical, Inc. PMI
AMEX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 156.87% | 13.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 156.87% | 13.97% | |||
| Cost of Revenue | 167.20% | 46.32% | |||
| Gross Profit | 124.00% | -33.09% | |||
| SG&A Expenses | 33.90% | 0.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 33.95% | 41.10% | |||
| Operating Income | -2.62% | -50.22% | |||
| Income Before Tax | 25.77% | -77.65% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 25.68% | -77.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 25.68% | -77.49% | |||
| EBIT | -2.62% | -50.22% | |||
| EBITDA | -2.67% | -50.69% | |||
| EPS Basic | 41.55% | -75.73% | |||
| Normalized Basic EPS | 9.27% | 15.70% | |||
| EPS Diluted | 41.55% | -75.73% | |||
| Normalized Diluted EPS | 9.27% | 15.70% | |||
| Average Basic Shares Outstanding | -97.56% | 1.00% | |||
| Average Diluted Shares Outstanding | -97.56% | 1.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||